Estíbaliz Ugalde Zárraga | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Estíbaliz Ugalde Zárraga
Affiliation Hospital Universitario de Basurto
Country Spain
Scopus ID 8588014900
Documents 9
Citations 23
h-index 3
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0003-3877-3642

Estíbaliz Ugalde Zárraga

Hospital Universitario de Basurto, Spain

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate scientific originality, methodological quality, and measurable research impact. Estíbaliz Ugalde Zárraga has contributed to the fields of clinical microbiology and infectious diseases through peer-reviewed publications addressing bacterial pathogens, antimicrobial resistance, zoonotic infections, and diagnostic microbiology. Her published studies support evidence-based clinical practice and improve understanding of uncommon infectious conditions encountered in healthcare settings.[1]

Abstract

Estíbaliz Ugalde Zárraga has established a developing research profile focused on infectious diseases, diagnostic microbiology, and clinically significant bacterial pathogens. Her publications emphasize accurate diagnosis, antimicrobial resistance surveillance, and uncommon infectious presentations that contribute to improved patient management. Recent studies include investigations involving Shigella sonnei carrying blaCTX-M-15, Pasteurella canis, Neisseria animaloris, Prevotella oris, Whipple’s disease, and Capnocytophaga canis. Collectively, these works provide clinically relevant observations that strengthen microbiological knowledge and support evidence-based healthcare decision-making.[2]

Keywords

Clinical Microbiology, Infectious Diseases, Antimicrobial Resistance, Diagnostic Medicine, Bacterial Pathogens, Medicine and Health Sciences.

Introduction

Modern clinical microbiology depends upon timely identification of infectious organisms and accurate reporting of emerging resistance mechanisms. Research addressing rare infections and unusual clinical presentations contributes valuable evidence to physicians and laboratory specialists. Through publications in recognized medical journals, Estíbaliz Ugalde Zárraga has participated in expanding scientific understanding of infectious disease diagnosis while supporting continuous improvements in microbiological practice.[3]

Research Profile

According to the supplied scholarly indicators, the researcher has a Scopus Author ID of 8588014900 with 9 indexed documents, 23 citations, and an h-index of 3. The research portfolio is primarily associated with Medicine and Health Sciences, emphasizing microbiological diagnosis, infectious disease case investigations, antimicrobial resistance, and clinically relevant laboratory findings. Publications demonstrate collaboration within hospital-based research environments and contribute practical observations useful to clinicians and microbiologists.[1]

Research Contributions

  • Reported sexually transmitted Shigella sonnei carrying blaCTX-M-15 among men who have sex with men.
  • Documented clinically significant infections following animal bites involving uncommon bacterial species.
  • Published evidence on serious pleuropulmonary infections caused by Prevotella oris.
  • Contributed case-based knowledge on Whipple’s disease and rare microbiological presentations.
  • Supported clinical microbiology literature through peer-reviewed publications with practical diagnostic relevance.

Publications

Representative publications include First report of Shigella sonnei carrying blaCTX-M-15 (2024), Wound infection caused by Pasteurella canis and Neisseria animaloris after a dog bite (2023), Two cases of Prevotella oris causing serious pleuropulmonary infections (2023), Whipple’s disease with multiple presentation in a rheumatologic patient (2023), and Capnocytophaga canis describing uncommon infection associated with cats. These publications collectively illustrate sustained contributions to infectious disease literature.[4]

Research Impact

The available publication metrics indicate measurable scholarly visibility within the medical research community. Citation activity reflects the scientific relevance of published findings, while the research topics address practical healthcare challenges involving pathogen identification, antimicrobial resistance, and infectious disease management. Such work contributes to the ongoing advancement of laboratory medicine and evidence-based clinical practice.[5]

Award Suitability

Based on the documented scholarly record, publication portfolio, and contributions to clinical microbiology, the researcher demonstrates characteristics consistent with consideration for an Innovative Research Award. The combination of peer-reviewed publications, practical diagnostic relevance, and investigation of uncommon infectious conditions illustrates a research profile focused on advancing medical knowledge while supporting improved patient care.[1]

Conclusion

Estíbaliz Ugalde Zárraga has contributed to contemporary clinical microbiology through research addressing infectious diseases of medical importance. Her scholarly output, supported by indexed publications and citation metrics, reflects continued engagement in clinically applicable research. The documented body of work demonstrates scientific rigor, collaboration, and commitment to advancing knowledge within Medicine and Health Sciences.

References

  1. Elsevier. (n.d.). Scopus author details: Estíbaliz Ugalde Zárraga, Author ID 8588014900. Scopus.
    https://www.scopus.com/pages/authors/8588014900
  2. Ugalde Zárraga E., et al. (2024). First report of Shigella sonnei carrying blaCTX-M-15. Infection.
    https://doi.org/10.1007/s15010-024-02341-7
  3. Revista Española de Quimioterapia. Wound infection caused by Pasteurella canis and Neisseria animaloris after a dog bite.
    https://doi.org/10.37201/req/035.2023
  4. Revista Española de Quimioterapia. Two cases of Prevotella oris causing serious pleuropulmonary infections.
    https://doi.org/10.37201/req/001.2023
  5. Enfermedades Infecciosas y Microbiología Clínica. Capnocytophaga canis, una causa poco común de infección causada por gatos.
    https://doi.org/10.1016/j.eimc.2022.05.010

Charles Timumpi Nignang | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Charles Timumpi Nignang
Affiliation University for Development Studies
Country Ghana
Documents 3
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0009-0005-8929-5267

Charles Timumpi Nignang

University for Development Studies, Ghana

Charles Timumpi Nignang is a researcher affiliated with the University for Development Studies, Ghana, whose scholarly work focuses on medicine and public health with particular emphasis on adolescent health, reproductive health, qualitative health research, and community-centered healthcare interventions. His recent peer-reviewed publications contribute evidence supporting equitable access to healthcare services through culturally appropriate and participatory research approaches. His research demonstrates the importance of engaging young people, healthcare professionals, and families in designing sustainable health interventions within resource-limited settings. These contributions provide valuable insights for healthcare policy, implementation science, and preventive medicine while strengthening evidence-based public health practice.[1]

Abstract

This article summarizes the academic profile and research contributions of Charles Timumpi Nignang. His published studies emphasize youth sexual and reproductive health, cervical cancer prevention, peer-led health education, and qualitative healthcare research in Northern Ghana. Through collaborative and evidence-based investigations, his work contributes practical knowledge for strengthening public health services, promoting inclusive healthcare delivery, and informing future intervention strategies within diverse community settings.[2]

Keywords

Medicine, Public Health, Adolescent Health, Reproductive Health, Qualitative Research, Cervical Cancer Prevention, Peer-Led Intervention, Community Health, Ghana.

Introduction

Healthcare research addressing youth engagement and preventive medicine has become increasingly important in improving long-term health outcomes. Charles Timumpi Nignang’s research aligns with these priorities by exploring barriers to healthcare access, promoting participatory intervention design, and evaluating culturally appropriate approaches that support equitable healthcare delivery.[3]

Research Profile

His current scholarly record includes three peer-reviewed journal publications in internationally recognized medical journals. The research primarily applies qualitative methodologies to understand healthcare experiences among adolescents, healthcare workers, and families. These investigations support evidence-informed decision-making while contributing to implementation research in reproductive and preventive healthcare.[1]

Research Contributions

  • Investigated youth access to sexual and reproductive health services.
  • Developed formative evidence for peer-led contraceptive counselling programs.
  • Examined family-centered approaches supporting cervical cancer prevention.
  • Applied qualitative methods to strengthen community-based healthcare interventions.

Publications

  • A Qualitative Study on Youth and Healthcare Provider Perspectives on Youth Access to Sexual and Reproductive Health Services in Northern Ghana.
  • Co-Designing a Peer-Led Contraceptive Counselling Program in Northern Ghana.
  • My Wife’s Healthcare Is My Healthcare.

Research Impact

The published studies provide evidence supporting adolescent reproductive health services, peer-supported counselling models, and family engagement in preventive healthcare. These contributions are relevant to public health practitioners, researchers, policymakers, and healthcare organizations seeking practical approaches for improving health outcomes within community settings.[4]

Award Suitability

Based on the available scholarly record, Charles Timumpi Nignang demonstrates active research engagement in medicine and health sciences through peer-reviewed publications addressing significant public health challenges. His research aligns with the objectives of the Innovative Research Award by emphasizing scientific evidence, healthcare innovation, community participation, and knowledge translation.[5]

Conclusion

Charles Timumpi Nignang’s publications contribute to contemporary discussions surrounding adolescent health, preventive medicine, and community-centered healthcare delivery. His qualitative research offers practical evidence that may support future public health interventions and collaborative healthcare initiatives in Ghana and similar settings.

References

  1. Elsevier. (n.d.).  Author details: Charles Timumpi Nignang
  2. International Journal of Environmental Research and Public Health. (2026). A Qualitative Study on Youth and Healthcare Provider Perspectives on Youth Access to Sexual and Reproductive Health Services in Northern Ghana.
    https://doi.org/10.3390/ijerph23070915
  3. Journal of Adolescent Health. (2026). Co-Designing a Peer-Led Contraceptive Counselling Program in Northern Ghana.
    https://doi.org/10.1016/j.jadohealth.2025.12.221
  4. Cancer Control. (2026). My Wife’s Healthcare Is My Healthcare.
    https://doi.org/10.1177/10732748261448259
  5. International Forensic Scientist Awards. (2026). Innovative Research Award.
    forensicscientist.org

Yury Kustov | Medicine and Health Sciences | Best Researcher Award

Best Researcher Award

Yury Kustov
Peoples’ Friendship University of Russia
Yury Kustov
Affiliation Peoples’ Friendship University of Russia
Country Russia
Scopus ID 58987836800
Documents 5
Citations 4
h-index 1
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0009-0002-4859-4322

Yury Kustov is a researcher affiliated with the Peoples’ Friendship University of Russia whose scholarly work focuses on medicine, pharmacovigilance, drug safety, pulmonary fibrosis, and clinical pharmacology. His recent publications examine adverse drug reactions, pediatric pharmacotherapy, pulmonary complications, and systematic reviews related to pharmacokinetics and post-COVID-19 outcomes. Through contributions indexed in Scopus, Kustov has participated in interdisciplinary investigations concerning patient safety and evidence-based medical analysis.[1] His profile reflects active engagement in healthcare-related research areas associated with pharmacological monitoring and clinical risk assessment.[2]

Abstract

The academic contributions of Yury Kustov are associated with contemporary clinical medicine and pharmacovigilance research. His published studies explore adverse drug reactions, pulmonary fibrosis, antibiotic safety, and pediatric therapeutic outcomes. Several investigations emphasize spontaneous report database analysis and systematic reviews in order to improve healthcare monitoring and pharmacological safety standards.[3] These contributions support broader scientific discussions regarding medication-related complications and patient-centered clinical evaluation.

Keywords

Pharmacovigilance, Clinical Pharmacology, Pulmonary Fibrosis, Pediatric Medicine, Drug Safety, Post-COVID Research, Pharmacokinetics, Medicine and Health Sciences.

Introduction

The advancement of modern healthcare increasingly depends on pharmacological safety assessment and evidence-based therapeutic monitoring. Researchers involved in pharmacovigilance contribute to the identification of adverse reactions and clinical complications linked to pharmaceutical interventions. Yury Kustov has participated in this research landscape through studies addressing antibacterial drug reactions, pulmonary fibrosis, and pediatric medicine.[4] His publications demonstrate engagement with healthcare datasets and clinical literature reviews that contribute to scientific understanding of treatment-related risks.

Research Profile

Kustov’s academic profile includes journal articles and conference publications indexed through Scopus and related scholarly databases. His research areas include pharmacokinetics in chronic heart failure, pulmonary fibrosis associated with pharmacotherapy, and pediatric antibacterial drug safety. The researcher has also examined Stevens–Johnson syndrome and toxic epidermal necrolysis using spontaneous reporting systems.[5] These studies align with medical efforts to improve treatment evaluation and patient safety methodologies.

Research Contributions

  • Analysis of fluoroquinolone safety in pediatric populations through pharmacovigilance database studies.
  • Systematic review research concerning pharmacokinetic alterations in chronic heart failure patients.
  • Investigations into pulmonary fibrosis and post-COVID-19 pharmacotherapy outcomes.
  • Evaluation of spontaneous adverse drug reaction reports linked to antibacterial medications.

Publications

  • “Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis”
  • “Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review”
  • “Drug-Induced Pulmonary Fibrosis: National Database Analysis”

Research Impact

The research contributions of Yury Kustov demonstrate relevance to healthcare monitoring, medication safety assessment, and evidence-based pharmacology. By utilizing systematic reviews and spontaneous report analyses, his studies contribute to discussions surrounding adverse drug reaction surveillance and therapeutic evaluation. Such research supports clinicians, pharmacologists, and healthcare researchers seeking to understand treatment-related complications in vulnerable patient populations.

Award Suitability

Yury Kustov’s publication record and involvement in pharmacovigilance-related medical studies align with the objectives of the International Forensic Scientist Awards. His focus on drug safety analysis, pulmonary complications, and healthcare risk assessment reflects scholarly engagement with medically significant challenges. The integration of database-driven clinical analysis and systematic review methodologies further demonstrates research activity associated with modern healthcare science and patient protection initiatives.

Conclusion

Yury Kustov has contributed to medicine and health sciences through publications examining pharmacovigilance, pulmonary fibrosis, clinical pharmacology, and pediatric drug safety. His academic profile reflects ongoing participation in evidence-based medical research and healthcare monitoring studies. Through indexed scholarly outputs and DOI-linked publications, his work contributes to the broader scientific understanding of pharmaceutical safety and patient-centered clinical investigation.

References

  1. Elsevier. (n.d.). Scopus author details: Yury Kustov, Author ID 58987836800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58987836800
  2. ORCID. (n.d.). Yury Kustov ORCID profile.
    https://orcid.org/0009-0002-4859-4322
  3. Kustov, Y. (2026). Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis.
    https://doi.org/10.1177/09246479251398995
  4. Kustov, Y. (2025). Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review.
    https://doi.org/10.3390/ijms26199495
  5. Kustov, Y. (2024). Drug-Induced Pulmonary Fibrosis: National Database Analysis.
    https://doi.org/10.3390/biomedicines12122650

Hong Zhang | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Hong Zhang
University of Texas Southwestern Medical Center, United States
Hong Zhang
Affiliation University of Texas Southwestern Medical Center
Country United States
Scopus ID 57192482890
Documents 28
Citations 550
h-index 13
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0003-3056-0343

Hong Zhang, is an orthopedic surgeon, biomedical innovator, and musculoskeletal research specialist affiliated with the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children in Dallas, Texas. His research activities focus primarily on pediatric spinal deformities, growth modulation, spinal instrumentation development, scoliosis correction technologies, and minimally invasive spinal surgery. Through a combination of clinical orthopedic expertise and translational biomedical engineering, Zhang has contributed to the development of novel surgical systems and patented technologies intended to improve the treatment of severe spinal deformities and early-onset scoliosis.[1]

As Director of the Division of Creative Innovations within the Seay Center for Musculoskeletal Research, Zhang has overseen multidisciplinary investigations involving experimental spine biomechanics, orthopedic implant design, pediatric spine growth modulation, and surgical correction strategies. His publication record, citation metrics, and patent portfolio demonstrate sustained scholarly engagement in orthopedic research and spinal deformity innovation.[2]

Abstract

Hong Zhang is recognized for contributions to orthopedic surgery research, spinal deformity correction technologies, and pediatric musculoskeletal innovation. His work has focused on improving surgical outcomes for severe scoliosis and kyphosis through biomechanical research, implant design, and translational clinical investigations. Zhang has also contributed to orthopedic device development through multiple United States patents related to spinal correction systems and stabilization technologies.[3] His scholarly publications in journals such as Spine Deformity, European Spine Journal, and Seminars in Spine Surgery highlight continued engagement in experimental spine research and orthopedic innovation.[4]

Keywords

Orthopedic Surgery, Pediatric Scoliosis, Spinal Deformity, Spine Research, Musculoskeletal Innovation, Early-Onset Scoliosis, Orthopedic Instrumentation, Growth Modulation, Biomedical Engineering, Pediatric Orthopedics

Introduction

The field of pediatric spinal deformity research requires coordinated advances in biomechanics, surgical techniques, implant engineering, and long-term clinical evaluation. Hong Zhang has contributed to this interdisciplinary area through research addressing early-onset scoliosis, thoracic deformities, vertebral correction systems, and growth-preserving spinal interventions. His investigations combine experimental orthopedic science with clinically applicable instrumentation design.[5]

Zhang obtained his medical degree from Tianjin Medical University in China and completed orthopedic surgery training at Tianjin Hospital before undertaking international orthopedic research and clinical scholarship programs in Italy and the United States. Since joining the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children, he has participated in numerous collaborative orthopedic research initiatives focused on pediatric spine disorders and surgical innovation.[6]

Research Profile

Hong Zhang currently serves as Director of the Division of Creative Innovations within the Center of Excellence in Spine Research at the Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas. He also holds the academic position of Associate Professor in the Department of Orthopaedic Surgery at the University of Texas Southwestern Medical Center.[1]

His research profile demonstrates sustained focus on pediatric spinal deformities, including early-onset scoliosis, thoracic kyphosis, spinal growth modulation systems, minimally invasive thoracoscopic procedures, and spinal instrumentation biomechanics. Zhang’s work frequently integrates engineering methodologies, experimental spine models, and translational orthopedic device development.[7]

  • Early-onset scoliosis and pediatric spine growth research
  • Orthopedic implant and spinal instrumentation development
  • Growth modulation systems for spinal correction
  • Biomechanical evaluation of spinal deformity devices
  • Experimental and translational musculoskeletal research
  • Minimally invasive spinal surgical technologies

Research Contributions

Zhang has contributed extensively to the development of innovative spinal correction systems intended for severe spinal deformities and pediatric scoliosis treatment. His patented orthopedic technologies include spinal rod reduction devices, pedicle screw systems, stabilization fasteners, and hinge-link spinal correction devices designed to improve alignment control and surgical correction efficiency.[8]

A significant component of his recent research involves the development of growth modulation systems using dynamic spinal correction approaches. Experimental investigations involving porcine models and three-dimensional simulation technologies have supported the evaluation of biomechanical effectiveness and safety profiles of novel correction systems.[9]

Zhang’s work on vertebral column resection systems and angular kyphosis reduction devices has also contributed to understanding correction strategies for severe thoracic spinal deformities. These studies have explored both implant mechanics and surgical feasibility in complex deformity correction procedures.[10]

  • Development of hinge-link spinal correction technologies
  • Novel uniplanar correction systems for angular kyphosis
  • Dynamic scoliosis correction and growth modulation research
  • Biomechanical studies of pediatric spinal instrumentation
  • Experimental orthopedic implant design and testing

Publications

Hong Zhang has authored and co-authored multiple peer-reviewed scientific publications addressing pediatric scoliosis, thoracic deformity correction, spine biomechanics, and orthopedic surgical technologies.[11]

  1. Zhang H, Lima JM, Jo CH, and Sucato DJ. The closing triradiate cartilage stage identifies accelerated curve progression in idiopathic scoliosis. Spine Deformity (2026).
  2. Zhang H, Ross D, and Sucato DJ. Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis. European Journal of Orthopaedic Surgery & Traumatology (2026).
  3. Zhang H, Ross D, and Sucato DJ. A new uniplanar correction strategy for severe thoracic kyphosis: concept, device design, and simulation with a 3D-printed model. Spine Deformity (2026).
  4. Zhang H, Niese B, and Sucato DJ. Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system: a porcine model study. Spine Deformity (2026).
  5. Brooks JT, Carron CJ, Zhang H, and Sucato DJ. Going anterior for the surgical management of pediatric scoliosis: Indications and technique pearls. Seminars in Spine Surgery (2025).

Research Impact

According to available Scopus metrics, Zhang has produced 28 indexed scholarly documents with approximately 550 citations and an h-index of 13, reflecting measurable academic influence within orthopedic surgery and musculoskeletal research communities.[1] His research output has contributed to the scientific understanding of pediatric spinal deformities, spinal growth dynamics, and orthopedic implant biomechanics.

His work has also received recognition through national and international awards, including the John H. Moe Award for Best Basic Science presented by the Scoliosis Research Society in both 2009 and 2010.[12] Additional grant support from organizations such as the Pediatric Orthopedic Society of North America and the Scoliosis Research Society further reflects the relevance of his investigations within pediatric orthopedic research.

Award Suitability

Hong Zhang’s academic profile aligns with the objectives of the Innovative Research Award due to his sustained contributions to orthopedic surgery innovation, spinal deformity correction technologies, and translational pediatric spine research. His work demonstrates interdisciplinary integration between clinical orthopedic practice, biomechanical engineering, and experimental medical device development.[8]

The combination of peer-reviewed publications, patented surgical systems, funded research projects, and international scientific recognition supports consideration of Zhang’s contributions within the field of medicine and health sciences. His focus on improving treatment strategies for complex pediatric spinal conditions reflects ongoing commitment to clinically relevant biomedical innovation.[10]

Conclusion

Hong Zhang has established a scholarly and clinical research profile centered on pediatric orthopedic innovation and spinal deformity correction. Through collaborative orthopedic research, patented instrumentation systems, and translational experimental studies, he has contributed to the advancement of spinal surgery technologies and pediatric musculoskeletal care. His publication history, research awards, and scientific contributions collectively support recognition within international academic and biomedical innovation platforms.[11]

References

  1. Elsevier. (n.d.). Scopus author details: Hong Zhang, Author ID 57192482890. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57192482890
  2. University of Texas Southwestern Medical Center. (n.d.). Faculty and research profile information for Hong Zhang.
  3. United States Patent and Trademark Office. (2010). Method for the Correction of Spinal Deformities Using Rod-Plate Anterior System.
  4. Springer Nature. (2026). Spine Deformity journal publications authored by Hong Zhang.
  5. Zhang H, Ross D, and Sucato DJ. (2026). Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis.
    https://doi.org/10.1007/s00590-026-04778-y
  6. Texas Scottish Rite Hospital for Children. (n.d.). Seay Center for Musculoskeletal Research profile.
  7. Zhang H, Niese B, and Sucato DJ. (2026). Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system.
    https://doi.org/10.1007/s43390-026-01284-3
  8. United States Patent and Trademark Office. (2023). Hinge-Link Spinal Correction Device and Method.
  9. Wang XB, Zhang H, and Sucato DJ. (2023). Unilateral thoracic spinal nerve resection creates early onset thoracic scoliosis in an immature porcine model.
    https://doi.org/10.1007/s00586-023-07804-3
  10. Zhang H, Ross D, and Sucato DJ. (2024). A Novel Uniplanar Clamp-Hinge Correction System for Vertebral Column Resection of Severe Angular Kyphosis.
    https://doi.org/10.1007/s43390-023-00770-2
  11. Elsevier. (n.d.). Publication and citation metrics for Hong Zhang in orthopedic research.
  12. Scoliosis Research Society. (2010). John H. Moe Award for Best Basic Science.

Zhanbo Qu | Medicine | Best Researcher Award

Dr. Zhanbo Qu | Medicine | Best Researcher Award

Huzhou central hospital | China

Dr. Qu Zhanbo is a dedicated medical professional at Huzhou Central Hospital, with a focus on microbiology, oncology, and gastroenterology. As a researcher, Dr. Qu has made significant contributions to the scientific community, publishing multiple papers in esteemed journals. His academic journey is marked by exceptional achievements, including being recognized as a top graduate innovative talent during his master’s studies.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Research Productivity: Qu Zhanbo has published 2 SCI papers as the first author, 3 SCI papers as a total of first author, and contributed to 16 SCI papers overall. This demonstrates consistent research output and collaboration.

  • Interdisciplinary Focus: His research spans microbiology, oncology, and gastroenterology — fields with significant impact on healthcare, especially in understanding colorectal cancer risk.

  • Recognition and Innovation: Awarded as a top graduate Innovative Talent during his master’s studies, reflecting early recognition for his research potential.

  • Patent Development: Involved in the development of dissolving microneedles of Clostridium butyricum and oxaliplatin, indicating a focus on translational research and innovation.

  • Diverse Publications: Contributions to reputable journals like Aging and Disease, Aging-US, Digestion, and Microbial Biotechnology highlight his research’s acceptance in well-regarded scientific communities.

Education 🎓

Dr. Qu Zhanbo pursued his medical education with a deep interest in understanding complex diseases and their microbial interactions. His academic path laid the foundation for his subsequent research endeavors, where he explored the intersection of microbiology and oncology.

Experience 💼

Currently serving at Huzhou Central Hospital, Dr. Qu combines clinical practice with groundbreaking research. His work spans various domains, including the association of Peptostreptococcus stomatis with colorectal cancer risk. Over the years, he has authored multiple SCI papers and contributed extensively to scientific literature, showcasing his expertise and commitment to advancing medical knowledge.

Research Interests On Medicine🔬

Dr. Qu’s research interests lie at the crossroads of microbiology, oncology, and gastroenterology. His investigations delve into microbial influences on cancer development, aiming to uncover novel insights that could lead to improved diagnostic and therapeutic strategies.

Awards 🏆

Dr. Qu’s academic and research excellence have been recognized through several accolades, including being awarded as a top graduate innovative talent during his master’s studies. This honor reflects his exceptional contributions to scientific inquiry and innovation.

Publications 📖

Dr. Qu has an impressive publication record, with notable papers such as:

  1. Multiple primary malignancies and gut microbiome

    • Year: 2025

    • Authors: Yinhang Wu, Zhanbo Qu, Zheng Wu, Jing Zhuang, Yingchen Wang, Zefeng Wang, Jian Chu, Quan Qi, Shuwen Han

  2. Fecal occult blood affects intestinal microbial community structure in colorectal cancer

    • Year: 2025

    • Authors: Wu Guodong, Wu Yinhang, Wu Xinyue, Shen Hong, Chu Jian, Qu Zhanbo, Han Shuwen

  3. Aging Gut Microbiome in Healthy and Unhealthy Aging

    • Year: 2024

    • Authors: Zhanbo Qu

  4. Classification of Colorectal Cancer Subtypes Based on Endoplasmic Reticulum Stress

    • Year: 2024

    • Authors: Zhanbo Qu, Jian Chu, Yinhang Wu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han

  5. Escherichia coli on colorectal cancer: A two‐edged sword

    • Year: 2024 (October)

    • Authors: Chu Jian, Wu Yinhang, Zhuang Jing, Qu Zhanbo, Wang Zefeng, Shuwen Han

  6. Deep learning application in prediction of cancer molecular alterations based on pathological images: a bibliographic analysis via CiteSpace

    • Year: 2024 (October)

    • Authors: Yu Xiaojian, Qu Zhanbo, Chu Jian, Wang Zefeng, Liu Jian, Liu Jin, Pan Yuefen, Han Shuwen

  7. Third-generation PacBio sequencing to explore gut bacteria and gender in colorectal cancer

    • Year: 2024 (July)

    • Authors: Sheng Yu, Jian Chu, Yinhang Wu, Jing Zhuang, Zhanbo Qu, Yifei Song, Xinyue Wu, Shuwen Han

  8. Age and aging process alter the gut microbes

    • Year: 2024 (April 8)

    • Authors: Qu Zhanbo, Zhuang Jing, Han Shugao, Wu Yinhang, Chu Jian, Yu Xiang, Zhao Feimin, Liu Jian, Wu Xinyue, Wu Wei et al.

  9. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule

    • Year: 2024 (March)

    • Authors: Jian Chu, Yinghang Wu, Zhanbo Qu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han

  10. Identification of enterotype and its predictive value for patients with colorectal cancer

  • Year: 2024 (February 27)

  • Authors: Li Qingbo, Zhuang Jing, Qu Zhanbo, Chu Jian, Song Yifei, Wu Yinhang, Han Shuwen

Conclusion 🔝

Dr. Qu Zhanbo stands out as a passionate researcher and dedicated doctor whose work bridges clinical practice and scientific exploration. His contributions to microbiology, oncology, and gastroenterology continue to shape the understanding of disease mechanisms and pave the way for future innovations in medical science.